Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,891 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing.
Patel JN, Robinson M, Morris SA, Jandrisevits E, Lopes KE, Hamilton A, Steuerwald N, Druhan LJ, Avalos B, Copelan E, Ghosh N, Grunwald MR. Patel JN, et al. Among authors: robinson m. Pharmacogenomics J. 2023 Nov;23(6):201-209. doi: 10.1038/s41397-023-00320-z. Epub 2023 Nov 4. Pharmacogenomics J. 2023. PMID: 37925536
Peripheral Immunotype Correlates with Minimal Residual Disease Status and Is Modulated by Immunomodulatory Drugs in Multiple Myeloma.
Bhutani M, Foureau D, Zhang Q, Robinson M, Wynn AS, Steuerwald NM, Druhan LJ, Guo F, Rigby K, Turner M, Slaughter D, Friend R, Atrash S, Symanowski JT, Avalos BR, Copelan EA, Voorhees PM, Usmani SZ. Bhutani M, et al. Among authors: robinson m. Biol Blood Marrow Transplant. 2019 Mar;25(3):459-465. doi: 10.1016/j.bbmt.2018.11.015. Epub 2018 Nov 24. Biol Blood Marrow Transplant. 2019. PMID: 30481597 Free article.
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant.
Patel JN, Hamadeh IS, Robinson M, Shahid Z, Symanowski J, Steuerwald N, Hamilton A, Reese ES, Plesca DC, Arnall J, Taylor M, Trivedi J, Grunwald MR, Gerber J, Ghosh N, Avalos B, Copelan E. Patel JN, et al. Among authors: robinson m. Clin Pharmacol Ther. 2020 Mar;107(3):571-579. doi: 10.1002/cpt.1642. Epub 2019 Oct 26. Clin Pharmacol Ther. 2020. PMID: 31549386
Thromboembolism Incidence and Risk Factors in Multiple Myeloma After First Exposure to Immunomodulatory Drug-Based Regimens.
Patel JN, Robinson M, Jagosky M, Slaughter D, Arnall J, Jandrisevits E, Matusz-Fisher A, Atrash S, Paul B, Bhutani M, Voorhees P, Usmani SZ. Patel JN, et al. Among authors: robinson m. Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):188-198.e2. doi: 10.1016/j.clml.2020.11.015. Epub 2020 Nov 28. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33339769 Review.
Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma.
Livingston MB, Jagosky MH, Robinson MM, Ahrens WA, Benbow JH, Farhangfar CJ, Foureau DM, Maxwell DM, Baldrige EA, Begic X, Symanowski JT, Steuerwald NM, Anderson CJ, Patt JC, Kneisl JS, Kim ES. Livingston MB, et al. Among authors: robinson mm. Clin Cancer Res. 2021 Dec 1;27(23):6424-6431. doi: 10.1158/1078-0432.CCR-21-2001. Epub 2021 Sep 2. Clin Cancer Res. 2021. PMID: 34475102 Clinical Trial.
Ex vivo efficacy of BCMA-bispecific antibody TNB-383B in relapsed/refractory multiple myeloma.
Foureau DM, Bhutani M, Robinson M, Guo F, Pham D, Buelow B, Steuerwald N, Rigby K, Tjaden E, Leonidas M, Paul BA, Atrash S, Ndiaye A, Symanowski JT, Voorhees PM, Usmani SZ. Foureau DM, et al. Among authors: robinson m. EJHaem. 2020 Aug 1;1(1):113-121. doi: 10.1002/jha2.69. eCollection 2020 Jul. EJHaem. 2020. PMID: 35847733 Free PMC article.
A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse.
Bhutani M, Foureau DM, Robinson M, Guo F, Fesenkova K, Atrash S, Paul B, Varga C, Friend R, Pineda-Roman M, Rigby K, Symanowski JT, Norek S, Tucker MR, Druhan LJ, Voorhees PM, Usmani SZ. Bhutani M, et al. Among authors: robinson m. Clin Lymphoma Myeloma Leuk. 2023 Jul;23(7):535-544.e1. doi: 10.1016/j.clml.2023.03.016. Epub 2023 Apr 7. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37127471 Clinical Trial.
5,891 results